Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin
- 499 Downloads
Baicalin is a flavonoid compound purified from the medicinal plant Scutellaria baicalensis Georgi and has been reported to possess anti-inflammatory and anti-viral activities. However, antiplatelet, anticoagulant, and profibrinolytic properties of baicalin have not been studied. In this study, the anticoagulant and antiplatelet activities of baicalin were measured by monitoring activated partial thromboplastin-time (aPTT), prothrombin time (PT), the activities of cell-based thrombin and activated factor X (FXa), platelet aggregation and thrombus formation. The effects of baicalin on the expressions of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were also tested in tumor necrosis factor-α (TNF-α) activated human umbilical vein endothelial cells (HUVECs). Our data showed that baicalin inhibited thrombin-catalyzed fibrin polymerization and platelet functions, prolonged aPTT and PT significantly and inhibited the activities and production of thrombin and FXa. Baicalin also prolonged in vivo bleeding time and inhibited TNF-α induced PAI-1 production. Furthermore, PAI-1/t-PA ratio was significantly decreased by baicalin. Collectively, these results indicate that baicalin possesses antithrombotic activities and suggest that the current study could provide bases for the development of new anticoagulant agents.
KeywordsBaicalin Fibrinolysis Anticoagulant Platelet
This study was supported by the National Research Foundation of Korea (NRF) funded by the Korea government [MSIP] (Grant no. 2013-067053).
Conflict of interest
The authors have no conflict of interest to declare.
- Berk, B.C., J.I. Abe, W. Min, J. Surapisitchat, and C. Yan. 2001. Endothelial atheroprotective and anti-inflammatory mechanisms. Annals of the New York Academy of Sciences 947, 93–109. discussion 109–11.Google Scholar
- Chen, Y.C., S.C. Shen, L.G. Chen, T.J. Lee, and L.L. Yang. 2001. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochemical Pharmacology 61: 1417–1427.CrossRefPubMedGoogle Scholar
- Hamaguchi, E., T. Takamura, A. Shimizu, and Y. Nagai. 2003. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. Journal of Pharmacology and Experimental Therapeutics 307: 987–994.CrossRefPubMedGoogle Scholar
- Hirano, T., S. Higa, J. Arimitsu, T. Naka, A. Ogata, Y. Shima, M. Fujimoto, T. Yamadori, T. Ohkawara, Y. Kuwabara, M. Kawai, H. Matsuda, M. Yoshikawa, N. Maezaki, T. Tanaka, and I. Kawase. 2006. Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem Biophys Res Commun 340: 1–7.CrossRefPubMedGoogle Scholar
- Izuhara, Y., S. Takahashi, M. Nangaku, S. Takizawa, H. Ishida, K. Kurokawa, C. Van Ypersele De Strihou, N. Hirayama, and T. Miyata. 2008. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arteriosclerosis, Thrombosis, and Vascular Biology 28, 672–677.Google Scholar
- Jauch, E.C., J.L. Saver, H.P. Adams Jr, A. Bruno, J.J. Connors, B.M. Demaerschalk, P. Khatri, P.W. Mcmullan Jr, A.I. Qureshi, K. Rosenfield, P.A. Scott, D.R. Summers, D.Z. Wang, M. Wintermark, and H. Yonas. 2013. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44: 870–947.CrossRefPubMedGoogle Scholar
- Ku, S.K., I.C. Lee, and JS. Bae. 2013. Antithrombotic activities of oroxylin A in vitro and in vivo. Archives of Pharmacal Research 33(5):787–792.Google Scholar
- Kubo, M., H. Matsuda, M. Tanaka, Y. Kimura, H. Okuda, M. Higashino, T. Tani, K. Namba, and S. Arichi. 1984. Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo) 32: 2724–2729.CrossRefGoogle Scholar
- Liu, W., M. Kato, A.A. Akhand, A. Hayakawa, M. Takemura, S. Yoshida, H. Suzuki, and I. Nakashima. 1998. The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases. International Journal of Oncology 12: 1321–1326.PubMedGoogle Scholar
- Sugo, T., C. Nakamikawa, S. Tanabe, and M. Matsuda. 1995. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. Journal of Biochemistry 117: 244–250.CrossRefPubMedGoogle Scholar